[go: up one dir, main page]

FR2877345B1 - FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF - Google Patents

FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF

Info

Publication number
FR2877345B1
FR2877345B1 FR0411782A FR0411782A FR2877345B1 FR 2877345 B1 FR2877345 B1 FR 2877345B1 FR 0411782 A FR0411782 A FR 0411782A FR 0411782 A FR0411782 A FR 0411782A FR 2877345 B1 FR2877345 B1 FR 2877345B1
Authority
FR
France
Prior art keywords
citrulin
rhe
fibrin
antibodies
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0411782A
Other languages
French (fr)
Other versions
FR2877345A1 (en
Inventor
Guy Serre
Mireille Sebbag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0411782A priority Critical patent/FR2877345B1/en
Application filed by Biomerieux SA filed Critical Biomerieux SA
Priority to US11/577,674 priority patent/US8207299B2/en
Priority to JP2007538475A priority patent/JP5060300B2/en
Priority to ES05815291T priority patent/ES2310853T3/en
Priority to AT05815291T priority patent/ATE401338T1/en
Priority to DE602005008277T priority patent/DE602005008277D1/en
Priority to EP05815291A priority patent/EP1814901B1/en
Priority to PCT/FR2005/002736 priority patent/WO2006048556A1/en
Publication of FR2877345A1 publication Critical patent/FR2877345A1/en
Application granted granted Critical
Publication of FR2877345B1 publication Critical patent/FR2877345B1/en
Priority to US13/489,072 priority patent/US9249208B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
FR0411782A 2004-11-04 2004-11-04 FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF Expired - Fee Related FR2877345B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0411782A FR2877345B1 (en) 2004-11-04 2004-11-04 FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF
JP2007538475A JP5060300B2 (en) 2004-11-04 2005-11-03 Fibrin-derived citrulline peptides recognized by rheumatoid arthritis-specific autoantibodies and uses thereof
ES05815291T ES2310853T3 (en) 2004-11-04 2005-11-03 CITRULINED PEPTIDES DERIVED FROM FIBRINE RECOGNIZED BY SPECIFIC SELF-AUTHORTIC BODIES OF REUMATOID POLYARTHRITIS AND USES OF THE SAME.
AT05815291T ATE401338T1 (en) 2004-11-04 2005-11-03 CITRULLINE PEPTIDES DERIVED FROM FIBRIN RECOGNIZED BY AUTOANTIBODIES SPECIFIC TO RHEUMATOID ARTHRITIS AND THE USE THEREOF
US11/577,674 US8207299B2 (en) 2004-11-04 2005-11-03 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof
DE602005008277T DE602005008277D1 (en) 2004-11-04 2005-11-03 CITRULLINPEPTIDES DERIVED FROM FIBRIN RECOGNIZED BY RHEUMATOID ARTHRITIS SPECIFIC AUTOANTIC BODIES AND THEIR USE
EP05815291A EP1814901B1 (en) 2004-11-04 2005-11-03 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof
PCT/FR2005/002736 WO2006048556A1 (en) 2004-11-04 2005-11-03 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof
US13/489,072 US9249208B2 (en) 2004-11-04 2012-06-05 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411782A FR2877345B1 (en) 2004-11-04 2004-11-04 FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF

Publications (2)

Publication Number Publication Date
FR2877345A1 FR2877345A1 (en) 2006-05-05
FR2877345B1 true FR2877345B1 (en) 2007-01-12

Family

ID=34950941

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0411782A Expired - Fee Related FR2877345B1 (en) 2004-11-04 2004-11-04 FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF

Country Status (1)

Country Link
FR (1) FR2877345B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795735B1 (en) * 1999-07-01 2001-09-07 Univ Toulouse CITRULLIN FIBRIN DERIVATIVES AND THEIR USE FOR DIAGNOSIS OR TREATMENT OF RHUMATOID POLYARTHRITIS

Also Published As

Publication number Publication date
FR2877345A1 (en) 2006-05-05

Similar Documents

Publication Publication Date Title
DE602005022897D1 (en) Piperidinylamino-THIENOÄ2,3-DT-pyrimidine
SI3670528T1 (en) Sclerostin-binding agents
ATE525377T1 (en) IMIDAZOÄ1,5-AÜPYRAZINE AS TYROSINKINASE INHIBITORS
EA200702643A1 (en) TWEAK ANTIBODIES
EP1773878A4 (en) INSULIN-OLIGOMERIC CONJUGATES, PREPARATIONS AND USES THEREOF
NL1025902A1 (en) Packaging.
EP1737961A4 (en) BOUGANIN PROTEINS, CYTOTOXINS AND METHODS AND USES THEREOF
DE502005007723D1 (en) 18-METHYL-19-NOR-17-pregn-4-ene-21,17-carbolactone,
EP1723247A4 (en) RECOMBINANT PERFORINE, EXPRESSION AND USES
DK1745009T3 (en) Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
DE602005007364D1 (en) cyclic peptides,
EP1865965A4 (en) 2-METHYLENE-19-NOR- (23S) -25-DEHYDRO-1H-HYDROXYVITAMINE D3-26,23-LACTONE AND 2-METHYLENE-19-NOR- (23R) -25-DEHYDRO-1H-HYDROXYVITAMIN D3- 26.23-LACTONES
DE502005002048D1 (en) NARROW SIDE-TO-MEASURED WEIGHING SYSTEM
FR2879604B1 (en) FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF
FR2877345B1 (en) FIBRIN-DERIVED CITRULIN PEPTIDES RECOGNIZED BY RHE-PATIENT-SPECIFIC AUTO-ANTIBODIES AND USES THEREOF
NL1031384A1 (en) Substituted aryl-1,4-pyrazine derivatives.
NO20081069L (en) Dynamic, application-expanding technology
ITMI20050051A1 (en) POLY-9-ORGANIC PHOTODIODIO DIOTTIL-FLUORENE
ES1055446Y (en) ARMABLE PACKAGING.
DE602004019824D1 (en) MODIFIED ETHYLENEDIAMIN N, N'-DIBERNIC ACID: ETHYLENEDIAMINE LYASE
DK1720557T3 (en) Fast-soluble, flavor-masked tablet
EP1860114A4 (en) CYCLIC NITROGUANOSIN-3, 5-MONOPHOSPHATE AND PROTEIN KINASE G ACTIVATOR
ES1058072Y (en) TOWEL-ANTI-WIND BAG.
ES1057641Y (en) FOLDING BOTTLE.
ES1056686Y (en) PACKABLE PACKAGING.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110801